Search

everythinglearnresearchcommunity

for

Search:↓

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

Compounds from turmeric and bitter show strong potential as antiviral agents against the influenza A virus.

Fluconazole might be a new treatment for a type of diabetes that affects water balance in the body.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

The IPP index is linked to storage symptoms and leftover urine, and may help manage urinary tract symptoms.

NSC167409 can effectively inhibit the virus causing hand, foot, and mouth disease.

VYN201 shows promise as a safe and effective treatment for non-segmental vitiligo.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Some small molecule antivirals show promise against COVID-19, but more research is needed to understand and improve them.

Certain medications can cause serious side effects, so it's important to report them.

China approved Sinovac's flu vaccine, Japan approved RiUP for female hair loss, and Nippon Kayaku's three cancer drugs.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Imipramine and pseudoephedrine treatment can effectively restore normal ejaculation in patients with diabetes, increasing their chances for pregnancy.

Finasteride may help improve certain brain function issues linked to dopamine.

Diphencyprone can cause unexpected and possibly permanent vitiligo.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

A new method effectively predicts estrogen-related health effects for early screening.

Cepharanthine may help treat lung fibrosis by affecting certain immune cells.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

Valproic acid is an effective and safe first-choice treatment for many types of seizures.

ExoFlo is safe and effective for treating Complex Regional Pain Syndrome symptoms.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Baricitinib and tofacitinib have different safety patterns in treating alopecia areata.

CAP7.1 is generally safe at 200 mg/m²/day, but can cause fatigue, nausea, hair loss, fever, and blood-related issues.

The research suggests Dutasteride and Solifenacin may be effective against the bacterium causing listeriosis.

A woman had a delayed allergic reaction to the blood thinner enoxaparin, treated with a steroid cream.